Literature DB >> 29684859

Isorhamnetin: A hepatoprotective flavonoid inhibits apoptosis and autophagy via P38/PPAR-α pathway in mice.

Xiya Lu1, Tong Liu2, Kan Chen3, Yujing Xia4, Weiqi Dai5, Shizan Xu6, Ling Xu7, Fan Wang8, Liwei Wu9, Jingjing Li10, Sainan Li11, Wenwen Wang12, Qiang Yu13, Jiao Feng14, Xiaoming Fan15, Yingqun Zhou16, Peiqin Niu17, Chuanyong Guo18.   

Abstract

Isorhamnetin, a flavonoid compound extracted from plants' fruit or leaves, like sea buckthorn (Hippophae rhamnoides L.), has many biological functions, including anti-tumor, anti-oxidant and anti-inflammatory effect. The present study is in order to explore the hepatoprotective effect of isorhamnetin on concanavalin A (ConA)-induced acute fulminant hepatitis and the underlying mechanism. Mice were injected with ConA (25 mg/kg) to induce acute fulminant hepatitis, three doses of isorhamnetin (10/30/90 mg/kg) was intraperitoneally administrated about 1 h previously. The serum and liver tissues were harvested at 2, 8, and 24 h after ConA injection. The levels of serum liver enzymes and proinflammatory cytokines were significantly reduced in isorhamnetin administration groups. Besides, isorhamnetin improved pathological damage. Furthermore, isorhamnetin affected P38/PPAR-α pathway, and subsequently regulated the expression of apoptosis and autophagy related proteins. The present study investigated that isorhamnetin inhibits apoptosis and autophagy via P38/PPAR-α pathway in mice.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  3-methylquercetin; Apoptosis; Autophagy; Concanavalin A; Hepatitis

Mesh:

Substances:

Year:  2018        PMID: 29684859     DOI: 10.1016/j.biopha.2018.04.016

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  14 in total

1.  Antiplatelet Activity of Isorhamnetin via Mitochondrial Regulation.

Authors:  Lyanne Rodríguez; Lina Badimon; Diego Méndez; Teresa Padró; Gemma Vilahur; Esther Peña; Basilio Carrasco; Hermine Vogel; Iván Palomo; Eduardo Fuentes
Journal:  Antioxidants (Basel)       Date:  2021-04-25

2.  Procyanidin B2 inhibits the activation of hepatic stellate cells and angiogenesis via the Hedgehog pathway during liver fibrosis.

Authors:  Jiao Feng; Chengfen Wang; Tong Liu; Jingjing Li; Liwei Wu; Qiang Yu; Sainan Li; Yuting Zhou; Jie Zhang; Jiaojiao Chen; Jie Ji; Kan Chen; Yuqing Mao; Fan Wang; Weiqi Dai; Xiaoming Fan; Jianye Wu; Chuanyong Guo
Journal:  J Cell Mol Med       Date:  2019-07-21       Impact factor: 5.310

3.  Isorhamnetin Inhibits Liver Fibrosis by Reducing Autophagy and Inhibiting Extracellular Matrix Formation via the TGF-β1/Smad3 and TGF-β1/p38 MAPK Pathways.

Authors:  Ning Liu; Jiao Feng; Xiya Lu; Zhilu Yao; Qing Liu; Yang Lv; Yuru Han; Jingfan Deng; Yingqun Zhou
Journal:  Mediators Inflamm       Date:  2019-07-31       Impact factor: 4.711

4.  The Protective Effects of Levo-Tetrahydropalmatine on ConA-Induced Liver Injury Are via TRAF6/JNK Signaling.

Authors:  Qiang Yu; Tong Liu; Sainan Li; Jiao Feng; Liwei Wu; Wenwen Wang; Kan Chen; Yujing Xia; Peiqin Niu; Ling Xu; Fan Wang; Weiqi Dai; Yingqun Zhou; Chuanyong Guo
Journal:  Mediators Inflamm       Date:  2018-12-04       Impact factor: 4.711

Review 5.  Therapeutic potential of PPARγ natural agonists in liver diseases.

Authors:  Liwei Wu; Chuanyong Guo; Jianye Wu
Journal:  J Cell Mol Med       Date:  2020-02-07       Impact factor: 5.310

6.  Bergenin Attenuates Hepatic Fibrosis by Regulating Autophagy Mediated by the PPAR-γ/TGF-β Pathway.

Authors:  Yujing Xia; Jingjing Li; Kan Chen; Jiao Feng; Chuanyong Guo
Journal:  PPAR Res       Date:  2020-12-31       Impact factor: 4.964

Review 7.  Autophagy regulation is an effective strategy to improve the prognosis of chemically induced acute liver injury based on experimental studies.

Authors:  Chenxia Hu; Lingfei Zhao; Miaoda Shen; Zhongwen Wu; Lanjuan Li
Journal:  J Cell Mol Med       Date:  2020-07-06       Impact factor: 5.310

8.  Evaluation of Garlic Landraces from Foggia Province (Puglia Region; Italy).

Authors:  Anna Bonasia; Giulia Conversa; Corrado Lazzizera; Pasqua Loizzo; Giuseppe Gambacorta; Antonio Elia
Journal:  Foods       Date:  2020-06-29

9.  The therapeutic effects and mechanisms of Long Chai Fang on chronic hepatitis B.

Authors:  Tingting Xu; Pei Wang; Xue Zheng; Zhanpeng Yan; Kun Li; Jindi Xu; Cuihua Jiang; Fangshi Zhu
Journal:  Ann Transl Med       Date:  2021-05

Review 10.  Nutraceutical Compounds Targeting Inflammasomes in Human Diseases.

Authors:  Beatriz Castejón-Vega; Francesca Giampieri; José M Alvarez-Suarez
Journal:  Int J Mol Sci       Date:  2020-07-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.